USANA Health Sciences Inc...

NYSE: USNA · Real-Time Price · USD
30.16
-0.37 (-1.21%)
At close: Aug 15, 2025, 12:49 PM

USANA Health Sciences Cash Flow Statement

Financials in USD. Fiscal year is February - January.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 29, 2025 Dec 28, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 30, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Jan 1, 2022 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021
Net Income
34.81M 42.06M 54.34M 55.08M 61.94M 63.79M 59.82M 63.4M 65.26M 69.35M 76.88M 89.28M 108.35M 116.5M 135.81M 138.99M 128.73M
Depreciation & Amortization
27.39M 22.23M 21.22M 20.82M 20.25M 20.39M 20.78M 21.04M 21.03M 21.41M 21.82M 21.88M 22.31M 22.19M 22.05M 22.16M 22.25M
Stock-Based Compensation
13.77M 14.56M 14.59M 14.72M 14.66M 14.6M 14.47M 13.87M 13.76M 13.33M 13.07M 13.45M 13.74M 14.3M 14.91M 14.99M 14.74M
Other Working Capital
-8.2M -9.62M -4.87M -11.36M -18M -11.98M 2.26M 1.56M -1.21M -12.37M -24.14M -18.99M -9.2M -13.79M -11.89M -5.18M 8.06M
Other Non-Cash Items
1.76M 1.89M 4.49M 4.15M 3.95M 14.71M 12.11M 12.15M 12.24M 141K 154K 22.06M 21.98M 22.03M 22.57M 630K 748K
Deferred Income Tax
-7.94M -6.74M -2.58M -2.64M -3.76M -2.75M -3.09M -5.38M -7.29M -7.18M -8.68M -4.02M -2.27M -2.97M -403K -2.87M -4.07M
Change in Working Capital
-11.01M -13M -10.83M -18.2M -21.03M -27.47M -6.38M -489K 4.13M 6.85M -14.88M -23.95M -20.87M -28.86M -28.75M -18.1M -13.13M
Operating Cash Flow
58.79M 60.99M 81.23M 73.93M 75.49M 70.64M 85.08M 91.97M 97.03M 103.9M 88.36M 96.72M 121.27M 121.23M 144.22M 155.79M 149.27M
Capital Expenditures
-9.68M -10.07M -15.6M -14.65M -15.59M -14.49M -10.46M -12.58M -10.72M -10.4M -10.27M -13.15M -12.96M -12.76M -11.09M -7.42M -9.43M
Cash Acquisitions
-203.34M -203.34M n/a 3K 3K n/a 3K -6.53M -13.06M -13.06M -13.06M -6.53M 5K 15K 15K 15K 13K
Purchase of Investments
870K n/a n/a -870K -870K -1.27M -1.27M 5.26M 11.79M 13.06M 14.62M 8.09M 1.55M n/a -21.55M -21.55M -21.55M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a 4.55M 9.11M 9.11M 9.11M 4.55M n/a n/a n/a n/a 1.94M
Other Investing Acitivies
-753K 322K 324K 1.13M 3.79M 2.52M 2.52M -2.03M -12.35M -11.08M -12.64M -8.07M -1.49M -1.42M 182K 227K 266K
Investing Cash Flow
-212.9M -213.09M -15.27M -14.39M -12.66M -11.97M -7.93M -10.06M -13.96M -12.37M -12.24M -15.11M -12.88M -14.19M -32.47M -28.75M -28.78M
Debt Repayment
21.68M 22.22M 8K 7K 1.33M 792K n/a n/a -10M n/a n/a n/a 10M n/a -46K -46K -46K
Common Stock Repurchased
-12.3M -9.44M -9.58M -21.21M -21.23M -14.65M -14.66M -3.11M -3.36M -25.88M -57.64M -104.36M -135.61M -177.84M -146.35M -99.62M -68.15M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.35M -3.22M -3.28M -3.25M -3.27M -3.43M -3.3M -3.25M -3.5M -4.51M -5.05M -5.11M -4.92M -3.58M -3.04M -3.02M -2.91M
Financial Cash Flow
7.03M 9.55M -12.72M -24.28M -22.98M -14.24M -15.04M -3.45M -13.69M -30.09M -62.38M -109.17M -130.53M -181.41M -149.44M -102.65M -71.06M
Net Cash Flow
-148.74M -148.74M 57.92M 32.23M 32.74M 41.93M 59.46M 68.91M 56.79M 47.67M -1.53M -34.52M -18.5M -72.28M -29.46M 38.36M 63.16M
Free Cash Flow
49.12M 50.92M 65.64M 59.28M 59.9M 56.15M 74.63M 79.39M 86.32M 93.5M 78.09M 83.57M 108.31M 108.46M 133.13M 148.38M 139.85M